Drug Shortage Report for ZERBAXA
| Report ID | 129756 |
| Drug Identification Number | 02446901 |
| Brand name | ZERBAXA |
| Common or Proper name | ceftolozane & tazobactam Powder for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTOLOZANE TAZOBACTAM |
| Strength(s) | 1G 0.5G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | ZERBAXA 1G/0.5G 10 VIAL |
| ATC code | J01DI |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2020-12-07 |
| Estimated end date | 2021-12-17 |
| Actual end date | 2021-12-10 |
| Shortage status | Resolved |
| Updated date | 2021-12-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2021-12-13 | French | Compare |
| v14 | 2021-12-13 | English | Compare |
| v13 | 2021-09-28 | French | Compare |
| v12 | 2021-09-28 | English | Compare |
| v11 | 2021-09-01 | French | Compare |
| v10 | 2021-09-01 | English | Compare |
| v9 | 2021-08-27 | French | Compare |
| v8 | 2021-08-27 | English | Compare |
| v7 | 2021-08-27 | English | Compare |
| v6 | 2021-06-21 | English | Compare |
| v5 | 2021-03-23 | English | Compare |
| v4 | 2020-12-08 | English | Compare |
| v3 | 2020-12-07 | French | Compare |
| v2 | 2020-12-07 | English | Compare |
| v1 | 2020-12-07 | English | Compare |
Showing 1 to 15 of 15